Skip to main content
. 2010 Nov 29;5(11):e15111. doi: 10.1371/journal.pone.0015111

Figure 1. Activity of formulated RC-101 is equivalent to unformulated peptide.

Figure 1

Antiviral activities of RC-101-containing films and placebo films against HIV-1 strain BaL were compared against unformulated “pure” RC-101 peptide in TZM-bl reporter assays expressed as percent inhibition of HIV-1 infection (A) and p24gag release assay in PM1 cells expressed in pg/ml of p24 released (B). p24gag differed between formulated and unformulated RC-101 at days 5 and 7, P<0.001 and P = 0.019, respectively. Error bars represent SEM; n = 2-5.